REFERENCE
EMA.European Medicines Agency confirms positive benefit-risk balance of Protelos/Osseor, but recommends new contraindications and revised warnings. Media Release: 16 Mar 2012. Available from: URL: http://www.ema.europa.eu
Rights and permissions
About this article
Cite this article
Benefits of strontium ranelate confirmed, new warnings required. React. Wkly. 1394, 4 (2012). https://doi.org/10.2165/00128415-201213940-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201213940-00013